News
Indo US Bio-Tech reports standalone net loss of Rs 3.67 crore in the September 2026 quarter
30-Oct-2026 | 17:11
Sales decline 51.22% to Rs 15.05 crore
Net loss of Indo US Bio-Tech reported to Rs 3.67 crore in the quarter ended September 2026 as against net profit of Rs 3.45 crore during the previous quarter ended September 2025. Sales declined 51.22% to Rs 15.05 crore in the quarter ended September 2026 as against Rs 30.85 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 15.05 | 30.85 | -51 |
| OPM % | -17.34 | 13.48 | - |
| PBDT | -3.37 | 3.77 | PL |
| PBT | -3.65 | 3.56 | PL |
| NP | -3.67 | 3.45 | PL |
Powered by Capital Market - Live News